The company’s gross profit this past quarter was $25.9 million, down 12.2 percent from the same period last year. Net sales were also down 3 percent, from $124.5 million in 2012 to $120.8 million in 2013.
More Articles on Devices:
Medical Device Tax Costs Will Be Absorbed by Companies, Not Passed to Hospitals
Orthofix’s Slumped Spine, Orthopedic Sales Brought 17% Gross Profit Drop in Q1
Misonix Names Scott Ludecker VP of Global Sales & Marketing
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
